{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,14]],"date-time":"2026-06-14T16:52:49Z","timestamp":1781455969119,"version":"3.54.1"},"reference-count":47,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,2,27]],"date-time":"2027-02-27T00:00:00Z","timestamp":1803686400000},"content-version":"am","delay-in-days":363,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100007188","name":"Uniformed Services University of the Health Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007188","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017540","name":"National Heart Lung and Blood Institute Division of Intramural Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017540","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.jtha.2025.11.013","type":"journal-article","created":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T17:32:41Z","timestamp":1765560761000},"page":"926-942","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["T cells from individuals with and without hemophilia A respond to the same epitopes in factor VIII"],"prefix":"10.1016","volume":"24","author":[{"given":"Pooja","family":"Vir","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad Faisal","family":"Karim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Devi","family":"Gunasekera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allen I.","family":"Stering","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth","family":"Lieuw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shannon L.","family":"Meeks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6837-6133","authenticated-orcid":false,"given":"Kathleen P.","family":"Pratt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtha.2025.11.013_bib1","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1182\/bloodadvances.2017008706","article-title":"CD4 T cells specific for factor VIII are present at high frequency in healthy donors and comprise naive and memory cells","volume":"1","author":"Meunier","year":"2017","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtha.2025.11.013_bib2","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1055\/s-0037-1615873","article-title":"CD4+ T cell response to factor VIII in hemophilia A, acquired hemophilia, and healthy subjects","volume":"82","author":"Reding","year":"1999","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.11.013_bib3","doi-asserted-by":"crossref","DOI":"10.1002\/eji.202350506","article-title":"Frequency of natural regulatory T cells specific for factor VIII in the peripheral blood of healthy donors","volume":"54","author":"Menier","year":"2024","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jtha.2025.11.013_bib4","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1345195","article-title":"The self-reactive FVIII T cell repertoire in healthy individuals relies on a short set of epitopes and public clonotypes","volume":"15","author":"Porcheddu","year":"2024","journal-title":"Front Immunol"},{"key":"10.1016\/j.jtha.2025.11.013_bib5","article-title":"Six amino acid residues in a 1200 A2 interface mediate binding of factor VIII to an IgG4kappa inhibitory antibody","volume":"10","author":"Lin","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jtha.2025.11.013_bib6","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1055\/s-0037-1613463","article-title":"The preparation and phospholipid binding property of the C2 domain of human factor VIII","volume":"89","author":"Takeshima","year":"2003","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.11.013_bib7","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0178544","article-title":"Quantitative analysis of the CD4+ T cell response to therapeutic antibodies in healthy donors using a novel T cell:PBMC assay","volume":"12","author":"Schultz","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.jtha.2025.11.013_bib8","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0080239","article-title":"Limited promiscuity of HLA-DRB1 presented peptides derived of blood coagulation factor VIII","volume":"8","author":"van Haren","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jtha.2025.11.013_bib9","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1000048","article-title":"A systematic assessment of MHC class II peptide binding predictions and evaluation of a consensus approach","volume":"4","author":"Wang","year":"2008","journal-title":"PLoS Comput Biol"},{"key":"10.1016\/j.jtha.2025.11.013_bib10","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1186\/1471-2105-11-568","article-title":"Peptide binding predictions for HLA DR, DP and DQ molecules","volume":"11","author":"Wang","year":"2010","journal-title":"BMC Bioinformatics"},{"key":"10.1016\/j.jtha.2025.11.013_bib11","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1000107","article-title":"Quantitative predictions of peptide binding to any HLA-DR molecule of known sequence: NetMHCIIpan","volume":"4","author":"Nielsen","year":"2008","journal-title":"PLoS Comput Biol"},{"key":"10.1016\/j.jtha.2025.11.013_bib12","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1007\/s00251-013-0720-y","article-title":"NetMHCIIpan-3.0, a common pan-specific MHC class II prediction method including all three human MHC class II isotypes, HLA-DR, HLA-DP and HLA-DQ","volume":"65","author":"Karosiene","year":"2013","journal-title":"Immunogenetics"},{"key":"10.1016\/j.jtha.2025.11.013_bib13","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1186\/1471-2105-8-238","article-title":"Prediction of MHC class II binding affinity using SMM-align, a novel stabilization matrix alignment method","volume":"8","author":"Nielsen","year":"2007","journal-title":"BMC Bioinformatics"},{"key":"10.1016\/j.jtha.2025.11.013_bib14","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/9858","article-title":"Generation of tissue-specific and promiscuous HLA ligand databases using DNA microarrays and virtual HLA class II matrices","volume":"17","author":"Sturniolo","year":"1999","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.jtha.2025.11.013_bib15","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1186\/1471-2105-10-296","article-title":"NN-align. An artificial neural network-based alignment algorithm for MHC class II peptide binding prediction","volume":"10","author":"Nielsen","year":"2009","journal-title":"BMC Bioinformatics"},{"key":"10.1016\/j.jtha.2025.11.013_bib16","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1111\/j.1538-7836.2007.02762.x","article-title":"T-cell responses over time in a mild hemophilia A inhibitor subject: epitope identification and transient immunogenicity of the corresponding self-peptide","volume":"5","author":"James","year":"2007","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.11.013_bib17","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1182\/blood-2015-11-682468","article-title":"T cells from hemophilia A subjects recognize the same HLA-restricted FVIII epitope with a narrow TCR repertoire","volume":"128","author":"Ettinger","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2025.11.013_bib18","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1182\/blood-2009-01-200725","article-title":"Lineages of human T-cell clones, including T helper 17\/T helper 1 cells, isolated at different stages of anti-factor VIII immune responses","volume":"114","author":"Ettinger","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2025.11.013_bib19","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/j.1365-2516.2008.01905.x","article-title":"HLA-DR-restricted T-cell responses to factor VIII epitopes in a mild haemophilia A family with missense substitution A2201P","volume":"16","author":"Ettinger","year":"2010","journal-title":"Haemophilia"},{"key":"10.1016\/j.jtha.2025.11.013_bib20","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1182\/bloodadvances.2017013482","article-title":"FVIII proteins with a modified immunodominant T-cell epitope exhibit reduced immunogenicity and normal FVIII activity","volume":"2","author":"Ettinger","year":"2018","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtha.2025.11.013_bib21","doi-asserted-by":"crossref","first-page":"4073","DOI":"10.1182\/blood-2011-08-374645","article-title":"CD4+ T-cell epitopes associated with antibody responses after intravenously and subcutaneously applied human FVIII in humanized hemophilic E17 HLA-DRB1\u22171501 mice","volume":"119","author":"Steinitz","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2025.11.013_bib22","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.975680","article-title":"Modulating the microenvironment during FVIII uptake influences the nature of FVIII-peptides presented by antigen-presenting cells","volume":"13","author":"Lubich","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.jtha.2025.11.013_bib23","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1111\/j.1538-7836.2011.04202.x","article-title":"T-cell responses in two unrelated hemophilia A inhibitor subjects include an epitope at the factor VIII R593C missense site","volume":"9","author":"James","year":"2011","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.11.013_bib24","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1128641","article-title":"Hemophilia A subjects with an intron-22 gene inversion mutation show CD4(+) T-effector responses to multiple epitopes in FVIII","volume":"14","author":"Gunasekera","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.jtha.2025.11.013_bib25","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.cellimm.2015.10.008","article-title":"Engineering less immunogenic and antigenic FVIII proteins","volume":"301","author":"Pratt","year":"2016","journal-title":"Cell Immunol"},{"key":"10.1016\/j.jtha.2025.11.013_bib26","first-page":"2069","article-title":"Antigen-specific immunotherapy with apitopes suppresses generation of FVIII inhibitor antibodies in HLA-transgenic mice","volume":"6","author":"Pletinckx","year":"2022","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtha.2025.11.013_bib27","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1016\/j.jtha.2024.11.012","article-title":"EDUC8 Consortium. Exploring red blood cells as an antigen delivery system to modulate the immune response towards FVIII in hemophilia A","volume":"23","author":"Miranda","year":"2025","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.11.013_bib28","first-page":"2320","article-title":"Regulation of immune responses to therapeutic factor VIII by transplacental delivery of Fc-fused immunodominant factor VIII domains or peptides","volume":"110","author":"Reyes-Ruiz","year":"2025","journal-title":"Haematologica"},{"key":"10.1016\/j.jtha.2025.11.013_bib29","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.742695","article-title":"Induction of tolerance to therapeutic proteins with antigen-processing independent T cell epitopes: controlling immune responses to biologics","volume":"12","author":"Schurgers","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.jtha.2025.11.013_bib30","doi-asserted-by":"crossref","first-page":"D436","DOI":"10.1093\/nar\/gkae1092","article-title":"The Immune Epitope Database (IEDB): 2024 update","volume":"53","author":"Vita","year":"2025","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.jtha.2025.11.013_bib31","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1146\/annurev-immunol-082119-124838","article-title":"T cell epitope predictions","volume":"38","author":"Peters","year":"2020","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.jtha.2025.11.013_bib32","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1182\/bloodadvances.2018030452","article-title":"Peptides identified on monocyte-derived dendritic cells: a marker for clinical immunogenicity to FVIII products","volume":"3","author":"Jankowski","year":"2019","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtha.2025.11.013_bib33","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.cellimm.2015.11.001","article-title":"Hunting down factor VIII in the immunopeptidome","volume":"301","author":"Hartholt","year":"2016","journal-title":"Cell Immunol"},{"key":"10.1016\/j.jtha.2025.11.013_bib34","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/jth.14647","article-title":"Quantitative HLA-class-II\/factor VIII (FVIII) peptidomic variation in dendritic cells correlates with the immunogenic potential of therapeutic FVIII proteins in hemophilia A","volume":"18","author":"Diego","year":"2020","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.11.013_bib35","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1182\/blood-2014-09-599365","article-title":"Personalized Approaches to Therapies for Hemophilia Study I. Factor VIII gene variants and inhibitor risk in African American hemophilia A patients","volume":"126","author":"Gunasekera","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2025.11.013_bib36","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1046\/j.1538-7836.2003.00366.x","article-title":"Recognition of coagulation factor VIII by CD4+ T cells of healthy humans","volume":"1","author":"Hu","year":"2003","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.11.013_bib37","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1111\/j.1538-7836.2005.01309.x","article-title":"Identification and removal of a promiscuous CD4+ T cell epitope from the C1 domain of factor VIII","volume":"3","author":"Jones","year":"2005","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.11.013_bib38","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1182\/blood-2002-05-1369","article-title":"CD4+ T-cell clones specific for wild-type factor VIII: a molecular mechanism responsible for a higher incidence of inhibitor formation in mild\/moderate hemophilia A","volume":"101","author":"Jacquemin","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2025.11.013_bib39","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1002\/ajh.24777","article-title":"Acquired hemophilia A: updated review of evidence and treatment guidance","volume":"92","author":"Kruse-Jarres","year":"2017","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jtha.2025.11.013_bib40","doi-asserted-by":"crossref","first-page":"255","DOI":"10.2147\/JBM.S284804","article-title":"Acquired hemophilia A: current guidance and experience from clinical practice","volume":"13","author":"Pishko","year":"2022","journal-title":"J Blood Med"},{"key":"10.1016\/j.jtha.2025.11.013_bib41","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1111\/j.1538-7836.2007.02336.x","article-title":"Depletion of CD4+\/CD25high regulatory T cells may enhance or uncover factor VIII-specific T-cell responses in healthy individuals","volume":"5","author":"Kamate","year":"2007","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.11.013_bib42","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1182\/blood-2016-08-732123","article-title":"Monoepitopic anti-FVIII T-cell response","volume":"128","author":"Lacroix-Desmazes","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2025.11.013_bib43","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1111\/j.1538-7836.2009.03636.x","article-title":"Impact of polymorphisms of the major histocompatibility complex class II, interleukin-10, tumor necrosis factor-alpha and cytotoxic T-lymphocyte antigen-4 genes on inhibitor development in severe hemophilia A","volume":"7","author":"Pavlova","year":"2009","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.11.013_bib44","doi-asserted-by":"crossref","first-page":"2991","DOI":"10.3389\/fimmu.2019.02991","article-title":"Tolerating factor VIII: recent progress","volume":"10","author":"Lacroix-Desmazes","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.jtha.2025.11.013_bib45","article-title":"Editorial: tolerating factor VIII: novel strategies to prevent and reverse neutralizing anti-FVIII antibodies","volume":"11","author":"Lacroix-Desmazes","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.jtha.2025.11.013_bib46","doi-asserted-by":"crossref","first-page":"4983","DOI":"10.1182\/bloodadvances.2021004909","article-title":"Anti-FVIII antibodies in Black and White hemophilia A subjects: do F8 haplotypes play a role?","volume":"7","author":"Pratt","year":"2023","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtha.2025.11.013_bib47","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.3389\/fimmu.2017.01117","article-title":"Human Tregs made antigen specific by gene modification: the power to treat autoimmunity and antidrug antibodies with precision","volume":"8","author":"Adair","year":"2017","journal-title":"Front Immunol"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S153878362500889X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S153878362500889X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,14]],"date-time":"2026-06-14T16:04:01Z","timestamp":1781453041000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S153878362500889X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":47,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S153878362500889X"],"URL":"https:\/\/doi.org\/10.1016\/j.jtha.2025.11.013","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"T cells from individuals with and without hemophilia A respond to the same epitopes in factor VIII","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtha.2025.11.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc. on behalf of International Society on Thrombosis and Haemostasis.","name":"copyright","label":"Copyright"}]}}